Clinical Trials Directory

Trials / Completed

CompletedNCT02804867

Spot Depression Study

A Blood Test to Identify Persons at Risk of Developing Depression or Bipolar Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
University of Cambridge · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to identify signs of depression and bipolar disorder by measuring changes of certain molecules (biomarkers) that can be detected in dried blood spots. Our goal is to use these biomarkers to develop a diagnostic test to enable early treatment, which can lead to better patient outcomes.

Detailed description

Bipolar disorder and major depression are serious mental health conditions that have a devastating impact on patients, their families and friends, and society. Currently, no laboratory test exists for these disorders. We are trying to develop a molecular test based on blood spots (small spots of blood obtained from patients' fingertips that have been dried on special paper). Volunteers take part by filling out the questionnaire at www.spot-depression.org. They may then be selected to provide a dried blood spot, which can be collected at home using a kit that will be mailed to their address.

Conditions

Interventions

TypeNameDescription
PROCEDUREOnline questionnaire and self-administered blood spot

Timeline

Start date
2016-03-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-06-17
Last updated
2017-02-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02804867. Inclusion in this directory is not an endorsement.

Spot Depression Study (NCT02804867) · Clinical Trials Directory